Akers Biosciences, Inc. Contracts & Agreements

First Amendment to the TNF Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 26, 2024)

Stock Purchase Agreement, dated as of October 1, 2024, by and between TNF Pharmaceuticals, Inc. and Prevail Partners, LLC (Filed With SEC on October 7, 2024)

Form of Amendment to Series F-1 Long Term Warrant (Filed With SEC on August 19, 2024)

Form of Amendment to Series F-1 Short Term Warrant (Filed With SEC on August 19, 2024)

Form of Amendment to Series G Long Term Warrant (Filed With SEC on August 19, 2024)

Form of Amendment to Series G Short Term Warrant (Filed With SEC on August 19, 2024)

Form of Amendment Agreement, dated as of August 8, 2024, by and among TNF Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on August 14, 2024)

Form of Amendment Agreement, dated as of June 17, 2024, by and among MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on June 17, 2024)

General Release and Severance Agreement, by and between MyMD Pharmaceuticals, Inc. and Christopher Chapman, dated as of June 14, 2024 (Filed With SEC on June 17, 2024)

Form of Series G Long-Term Warrant (Filed With SEC on May 21, 2024)

Form of Series G Short-Term Warrant (Filed With SEC on May 21, 2024)

Form of Series F-1 Long-Term Warrant (Filed With SEC on May 21, 2024)

Form of Series F-1 Short-Term Warrant (Filed With SEC on May 21, 2024)

Form of Series G Purchase Agreement (Filed With SEC on May 21, 2024)

Form of Series F-1 Purchase Agreement (Filed With SEC on May 21, 2024)

Form of Series G Registration Rights Agreement (Filed With SEC on May 21, 2024)

Form of Series F-1 Registration Rights Agreement (Filed With SEC on May 21, 2024)

Form of Omnibus Waiver, Consent, Notice and Amendment, by and among MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on May 21, 2024)

Form of Amendment to Warrant, dated March 14, 2024, by and between MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on May 15, 2024)

Form of Omnibus Waiver and Amendment, dated April 5, 2024, by and between MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on April 8, 2024)

Description of Securities (Filed With SEC on April 1, 2024)

Seventh Amendment to Employment Agreement, dated September 6, 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Chris Chapman (Filed With SEC on April 1, 2024)

Agreement and Plan of Merger, dated March 4, 2024, by and between MyMD Pharmaceuticals, Inc., a New Jersey corporation, and MyMD Pharmaceuticals, Inc., a Delaware corporation (Filed With SEC on March 7, 2024)

Eighth Amendment to Employment Agreement, dated November 13 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Chris Chapman (Filed With SEC on November 14, 2023)

Fourth Amendment to Employment Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Adam Kaplin (Filed With SEC on November 14, 2023)

Employment Mutual Separation Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Paul M. Rivard (Filed With SEC on November 14, 2023)

First Amendment to Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Christopher C. Schreiber (Filed With SEC on November 14, 2023)

Description of Securities (Filed With SEC on March 31, 2023)

Third Amendment to Employment Agreement between Paul Rivard, Esq. and MyMD Pharmaceuticals, Inc., dated March 22, 2023 (Filed With SEC on March 23, 2023)

Form of Warrant (Filed With SEC on February 21, 2023)

Form of Purchase Agreement (Filed With SEC on February 21, 2023)

Engagement Letter, dated February 21, 2023 by and between MyMD Pharmaceuticals, Inc. and Katalyst Securities LLC (Filed With SEC on February 21, 2023)

Sixth Amendment to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated January 1, 2023 (Filed With SEC on February 3, 2023)

Fifth Amendment to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated August 30, 2022 (Filed With SEC on November 10, 2022)

Third Amendment to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals, Inc., dated August 30, 2022 (Filed With SEC on November 10, 2022)

Form of Warrant (Filed With SEC on August 15, 2022)

Form of Securities Purchase Agreement (Filed With SEC on August 15, 2022)

Description of Securities (Filed With SEC on March 31, 2022)

Form of Placement Agent Warrant Certificate (Filed With SEC on March 31, 2022)

Amendment No. 4 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated November 24, 2021 (Filed With SEC on March 31, 2022)

Amendment No. 2 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals, Inc., dated November 24, 2021 (Filed With SEC on March 31, 2022)

Asset Purchase Agreement, dated November 11, 2020, by and between MyMD Pharmaceuticals, Inc. and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)

MyMD Pharmaceuticals (Florida) Inc. Second Amendment to Amended and Restated 2016 Stock Incentive Plan, dated July 1, 2019 (Filed With SEC on May 18, 2021)

Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings II, LLC and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)

Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings, LLC and MyMD Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)

Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc., effective December 18, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 1 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc, dated February 11, 2021 (Filed With SEC on May 18, 2021)

Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., effective November 1, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 1 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 2 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated January 8, 2021 (Filed With SEC on May 18, 2021)

Amendment No. 3 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated February 11, 2021 (Filed With SEC on May 18, 2021)

Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated September 21, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 1 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated November 24, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 2 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020 (Filed With SEC on May 18, 2021)

MyMD Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on April 22, 2021)

Form of Nonqualified Stock Option Agreement (Filed With SEC on April 22, 2021)

Form of Incentive Stock Option Agreement (Filed With SEC on April 22, 2021)

Form of Restricted Stock Award Agreement (Filed With SEC on April 22, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Form of Placement Agent Warrant (Filed With SEC on November 18, 2020)

Agreement and Plan of Merger and Reorganization, dated November 11, 2020, by and among Akers Biosciences, Inc., XYZ Merger Sub Inc., and MYMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)

Form of Voting Agreement, by and between Akers Biosciences, Inc. and the directors, officers and certain specified stockholders of MyMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)

Form of Voting Agreement, by and between MYMD Pharmaceuticals, Inc. and the directors, officers and certain stockholders of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)

Form of Pre-Funded Warrant. of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)

Form of Investor Warrant. of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)

Form of Lock-Up/Leak-Out Agreement (Filed With SEC on November 12, 2020)

The Secured Promissory Note, dated November 11, 2020, by and between Akers Biosciences, Inc. and MYMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)

Form of Securities Purchase Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and purchasers named therein (Filed With SEC on November 12, 2020)

Form of Lock-Up and Support Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and its stockholders named therein (Filed With SEC on November 12, 2020)

Rights Agreement dated as of September 9, 2020 between Akers Biosciences, Inc. and VStock Transfer, LLC as Rights Agent (Filed With SEC on September 9, 2020)

Akers Biosciences, Inc. 2018 Plan Amendment (Filed With SEC on August 28, 2020)

Form of Placement Agent Warrant (Filed With SEC on August 13, 2020)

Form of Securities Purchase Agreement (Filed With SEC on August 13, 2020)

Settlement Agreement and General Release, dated as of August 3, 2020, by and among Akers Biosciences, Inc. and ChubeWorkx Guernsey Limited (Filed With SEC on August 10, 2020)

Leak-Out and Support Agreement, dated as of August 3, 2020, by and among Akers Biosciences, Inc. and ChubeWorkx Guernsey Limited (Filed With SEC on August 10, 2020)

CFO Consulting Agreement, dated as of July 21, 2020, between Akers Biosciences, Inc. and Brio Financial Group (Filed With SEC on July 22, 2020)

Amendment No. 1 to the Membership Interest Purchase Agreement, dated May 14, 2020 (Filed With SEC on May 15, 2020)

Form of Placement Agent Warrant (Filed With SEC on May 15, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 15, 2020)

Form of Placement Agent Warrant (Filed With SEC on April 8, 2020)

Form of Securities Purchase Agreement (Filed With SEC on April 8, 2020)

Description of Securities (Filed With SEC on March 25, 2020)

Membership Interest Purchase Agreement (Filed With SEC on March 24, 2020)

Support Agreement (Filed With SEC on March 24, 2020)

Registration Rights Agreement (Filed With SEC on March 24, 2020)

License Agreement (Filed With SEC on March 24, 2020)

Executive Chairman Agreement, dated January 31, 2020 (Filed With SEC on January 31, 2020)

Offer of Employment, dated January 6, 2020 (Filed With SEC on January 6, 2020)

Form of Series C Convertible Preferred Stock Warrant Certificate (Filed With SEC on November 29, 2019)

Form of Pre-Funded Warrant Certificate (Filed With SEC on November 29, 2019)

Form of Placement Agent Warrant Certificate (Filed With SEC on November 29, 2019)

Form of Securities Purchase Agreement (Filed With SEC on November 29, 2019)

Form of Akers Biosciences, Inc. 2018 Equity Incentive Plan (Filed With SEC on December 7, 2018)

Form of Warrant (Filed With SEC on October 31, 2018)

Form of Securities Purchase Agreement, dated October 31, 2018, by and among the Company and the investors signatory thereto (Filed With SEC on October 31, 2018)

Form of Resignation Agreement (Filed With SEC on October 12, 2018)

Offer of Employment, dated October 5, 2018 (Filed With SEC on October 12, 2018)

Form of Resignation Agreement (Filed With SEC on October 11, 2018)

Offer of Employment, dated October 5, 2018 (Filed With SEC on October 11, 2018)

Underwriting Agreement, dated December 18, 2017, between Akers Biosciences, Inc. and Joseph Gunnar & Co., LLC as representative of the several underwriters named therein (Filed With SEC on December 19, 2017)

Form of Underwriting Agreement (Filed With SEC on December 15, 2017)

Form of Underwriters Warrant (Filed With SEC on December 15, 2017)

Form of Underwriting Agreement (Filed With SEC on December 14, 2017)

Form of Underwriters Warrant (Filed With SEC on December 14, 2017)

Form of Stock Certificate of Series B Preferred Stock (Filed With SEC on December 14, 2017)

Form of Common Stock Purchase Warrant (Filed With SEC on December 14, 2017)

Form of Additional Warrant (Filed With SEC on October 13, 2017)

Form of Warrant Exercise Agreement, dated October 12, 2017, by and between Akers Biosciences, Inc. and certain Warrant Holders (Filed With SEC on October 13, 2017)

AKERSBIOSCIENCES, INC. 2017EQUITY INCENTIVE PLAN (Filed With SEC on August 11, 2017)

COMMONSTOCK PURCHASE WARRANT AKERSBIOSCIENCES, INC. (Filed With SEC on April 5, 2017)

[FORMOF PLACEMENT AGENT WARRANT] (Filed With SEC on April 5, 2017)

PLACEMENTAGENCY AGREEMENT (Filed With SEC on April 5, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 5, 2017)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on April 5, 2017)

UNDERWRITINGAGREEMENT Between AKERSBIOSCIENCES, INC. And JOSEPHGUNNAR & CO., LLC asRepresentative of the Several Underwriters (Filed With SEC on January 10, 2017)

AKERSBIOSCIENCES, INC. FORMOF COMMONSTOCK PURCHASE WARRANT (Filed With SEC on January 10, 2017)

FIRSTAMENDMENT TO AKERSBIOSCIENCES, INC. AMENDED AND RESTATED 2013 INCENTIVE STOCK AND AWARDPLAN (Filed With SEC on October 12, 2016)

EMPLOYMENTAGREEMENT (Filed With SEC on December 3, 2015)

AKERS BIOSCIENCES, INC. FIRST AMENDED AND RESTATED 2013 INCENTIVE STOCK AND AWARD PLAN (Filed With SEC on January 9, 2015)

LOCK-UP AGREEMENT (Filed With SEC on January 9, 2015)

DlO Joint Venture Agreement (Filed With SEC on October 29, 2014)

AKERS BIOSCIENCES, INC. 2013 INCENTIVE STOCK AND AWARD PLAN (Filed With SEC on December 6, 2013)

AKERS BIOSCIENCES, INC. NON-QUALIFIED STOCK OPTION AGREEMENT NON-EMPLOYEE (Filed With SEC on December 6, 2013)

AKERS BIOSCIENCES, INC. NON-QUALIFIED STOCK OPTION AGREEMENT EMPLOYEE (Filed With SEC on December 6, 2013)

AKERS BIOSCIENCES, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on December 6, 2013)

AKERS BIOSCIENCES, INC. INCENTIVESTOCK OPTION AGREEMENT (Filed With SEC on December 6, 2013)

Akers Biosciences, Inc. 201 Grove Rd, West Deptford, NJ (Filed With SEC on December 6, 2013)

UNDERWRITING AGREEMENT between AKERS BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on November 18, 2013)

Form of Representative’s Warrant Agreement (Filed With SEC on November 18, 2013)

PROMISSORY NOTE (Filed With SEC on November 18, 2013)

CONTENTS (Filed With SEC on October 8, 2013)

FISHER HEALTHCARE, ADIVISION OF FISHER SCIENTIFIC COMPANY L.L.C. (“FISHER”) DISTRIBUTION AGREEMENT (June 15, 2010 through May31, 2012) (the “Initial Term”) (Filed With SEC on October 8, 2013)

NATIONALBRAND DISTRIBUTION AGREEMENT (Filed With SEC on October 8, 2013)

EMPLOYMENTAGREEMENT (Filed With SEC on August 7, 2013)

CONSULTING SERVICES AGREEMENT (Filed With SEC on August 7, 2013)

ANNEX SCHEDULE7: EXISTING CUSTOMERS (Filed With SEC on August 7, 2013)

VOTING AGREEMENT (Filed With SEC on August 7, 2013)

SUBSCRIPTION AGREEMENT (Filed With SEC on August 7, 2013)

PROMISSORY NOTE (Filed With SEC on August 7, 2013)

Category

Industry

Companies

Contracts

Akers Biosciences, Inc. Contracts & Agreements